These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24995430)

  • 1. The use of iodinated contrast media in patients with end-stage renal disease.
    Khan SF; Kalantari K
    Semin Dial; 2014; 27(6):607-10. PubMed ID: 24995430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis for removal of iodinated contrast media.
    Rault RM
    Int J Artif Organs; 2001 Jun; 24(6):331-4. PubMed ID: 11482498
    [No Abstract]   [Full Text] [Related]  

  • 3. Elimination of ioversol by hemodialysis.
    Ueda J; Furukawa T; Takahashi S; Sakaguchi K
    Acta Radiol; 1996 Sep; 37(5):826-9. PubMed ID: 8915301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravascular iodinated contrast media on natural course of end-stage renal disease progression in hemodialysis patients: a prospective study.
    Janousek R; Krajina A; Peregrin JH; Dusilova-Sulkova S; Renc O; Hajek J; Dvorak K; Fixa P; Cermakova E
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):61-6. PubMed ID: 19830486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of low volume iodinated contrast administration for arteriovenous fistula intervention in chronic kidney disease stage 4 or 5 utilizing a bicarbonate prophylaxis strategy.
    Eisenhart E; Benson S; Lacombe P; Himmelfarb J; Zimmerman R; Schimelman B; Parker MG
    Semin Dial; 2010; 23(6):638-42. PubMed ID: 21175838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing complications of radiographic contrast media: is there a role for dialysis?
    Rodby RA
    Semin Dial; 2007; 20(1):19-23. PubMed ID: 17244114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of iopentol in patients with chronic renal failure.
    Svaland MG; Kolmannskog F; Lillevold PE; Nordal KP; Ressem L; Berg KJ
    Acta Radiol; 1992 Sep; 33(5):482-4. PubMed ID: 1389660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis.
    Younathan CM; Kaude JV; Cook MD; Shaw GS; Peterson JC
    AJR Am J Roentgenol; 1994 Oct; 163(4):969-71. PubMed ID: 8092045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of haemodialysis after contrast medium administration in patients with renal insufficiency.
    Lehnert T; Keller E; Gondolf K; Schäffner T; Pavenstädt H; Schollmeyer P
    Nephrol Dial Transplant; 1998 Feb; 13(2):358-62. PubMed ID: 9509446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
    Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
    Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast agents and ionization with respect to safety for patients and doctors.
    von Tengg-Kobligk H; Kara L; Klink T; Khanicheh E; Heverhagen JT; Böhm IB
    Contrib Nephrol; 2015; 184():59-74. PubMed ID: 25676292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does continuous venovenous hemodiafiltration concomitant with radiological procedures provide a significant and safe removal of the iodinated contrast ioversol?
    Gabutti L; Marone C; Monti M; Malfanti M; Zwahlen U; Pasotti E; Colucci G; Schönholzer C
    Blood Purif; 2003; 21(2):152-7. PubMed ID: 12601257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast agents in patients on dialysis.
    Dawson P
    Semin Dial; 2002; 15(4):232-6. PubMed ID: 12191023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.
    Benness G; Evill C; Wilcox J; Hassam R; Arozoo E
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():88-90. PubMed ID: 2568815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of the nonionic contrast medium iopromide in end-stage renal failure by hemodialysis.
    Kierdorf H; Kindler J; Winterscheid R; Hollmann HJ; Vorwerk D; Speck U
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989; 128():119-23. PubMed ID: 2568779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodinated contrast media and the role of renal replacement therapy.
    Weisbord SD; Palevsky PM
    Adv Chronic Kidney Dis; 2011 May; 18(3):199-206. PubMed ID: 21531326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P
    Acta Med Croatica; 2001; 55(4-5):177-86. PubMed ID: 12398021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P; Reiner Z; Brunetta B
    Lijec Vjesn; 2002; 124(11-12):372-7. PubMed ID: 12679979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.
    El-Assal MI; Helmy SA
    Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of gadolinium-DTPA in chronic renal insufficiency requiring dialysis].
    Krahe T; Götz R; Lackner K; Haustein J; Klemenz U; Landwehr P; Heidbreder E; Schuhmann-Giampieri G
    Rofo; 1992 Jun; 156(6):523-6. PubMed ID: 1617171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.